How Not To Cross FTC: Attorneys Offer Advice For Cosmeceutical Marketers
This article was originally published in The Rose Sheet
Claims for cosmeceuticals referred by the National Advertising Division go to the same place on the Federal Trade Commission's list of priorities as other disputed claims - straight to the top
You may also be interested in...
Skin-lightening claims appear to be on FDA's radar as it continues its crackdown on overreaching cosmetic marketing, issuing a warning letter to Golden Caviar Skin Care for statements promoting a whitening serum and cream, among other offerings. The company's Caviar Lifting and Firming Serum with Zinc also is an unapproved drug, based on claimed benefits including wound healing and acne relief, the agency says.
Claims cited in FDA’s warning to Avon Products Inc. include statements suggesting collagen-building and wrinkle-plumping benefits, as well as comparisons to in-clinic injections and the assertion that technology in the firm’s Anew Reversalist products can help “reactivate skin’s repair process to recreate fresh skin.” Avon has 15 days to reply.
Earthworm castings are a mainstay on organic farms for extending the life cycle of plants, but only now is the ingredient being used in skin care, touted to promote healthy stem cells.